Concentration-dependent opposite effects of 1-Benzyl-1,2,3,4- tetrahydroisoquinoline on markers of apoptosis: In vitro and ex vivo studies

Neurotoxicity Research

Volumn 25, Issue 1, 2014, Pages 90-99

  Wąsik, Agnieszka ^a   Kajta, Małgorzata ^a   Lenda, Tomasz ^a   Antkiewicz Michaluk, Lucyna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1 Benzyl 1,2,3,4 tetrahydroisoquinoline; Apoptosis; Caspase 3; Lactate dehydrogenase; Tyrosine hydroxylase; Synuclein

Indexed keywords

1 BENZYL 1,2,3,4 TETRAHYDROISOQUINOLINE; ALPHA SYNUCLEIN; CASPASE 3; LACTATE DEHYDROGENASE; TETRAHYDROISOQUINOLINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; 1,2,3,4-TETRAHYDRO-1-(PHENYLMETHYL)ISOQUINOLINE; BIOLOGICAL MARKER; GLUTAMIC ACID; TETRAHYDROISOQUINOLINE DERIVATIVE;

ACUTE DRUG ADMINISTRATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN CELL CULTURE; CHRONIC DRUG ADMINISTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; EX VIVO STUDY; IN VITRO STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR MECHANICS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; ANIMAL; CELL CULTURE; DRUG EFFECTS; HIPPOCAMPUS; METABOLISM; MITOCHONDRION; MOUSE; PATHOLOGY; PHYSIOLOGY; TOXICITY; WISTAR RAT;

RATTUS;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CASPASE 3; CELLS, CULTURED; GLUTAMIC ACID; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; MICE; MITOCHONDRIA; RATS; RATS, WISTAR; TETRAHYDROISOQUINOLINES;

EID: 84891865946     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-013-9436-x     Document Type: Article

References (41)

1. Antkiewicz-Michaluk L, Romańska I, Papla I, Michaluk J, Bakalarz M, Vetulani J, Krygowska-Wajs A, Szczudlik A (2000) Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol In dopaminergic structures of rat brain. Neuroscience 96:59-64 (Pubitemid 30103603)
2. Antkiewicz-Michaluk L, Michaluk J, Mokrosz M, Romańska I, Lorenc-Koci E, Otha S, Vetulani J (2001) Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. J Neurochem 78:100-108 (Pubitemid 32622592)
3. Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S (2001) Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett 497:1-5 (Pubitemid 32480171)
4. Bamberger ME, Landreth GE (2002) Inflammation, apoptosis, and Alzheimer's disease. Neuroscient 8:276-283 (Pubitemid 34538795)
5. Bayir H, Kapralovv AA, Jiang J, Huang Z, Tyurina YY, Tyurin VA, Zhao Q, Belikova NA, Vlasova II, Maeda A, Zhu J, Na HM, Mastroberardino PG, Sparvero LJ, Amoscato AA, Chu CT, Greenamyre JT, Kagan VE (2009) Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome c: protection against apoptosis versus delayed oxidative stress in Parkinson disease. J Biol Chem 284(23):15951-15969
6. Beal MF, Howell N, Bodis-Wollner I (1997) Mitochondria and free radicals in neurodegenerative disease. Wiley, New York
7. Behl C, Widmann M, Trapp T, Holsboer F (1995) 17-beta-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473-482
8. Burns RS, Lewitt PA, Ebert H, Pakkenberg H, Kopin IJ (1985) The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 312:1418-1421 (Pubitemid 15083659)
9. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262(5134):689-695 (Pubitemid 23350687)
10. Davis JB, Maher P (1993) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res 652(1):169-173
11. Froissard P, Duval D (1994) Cytotoxic effects of glutamic acid on PC12 cells. Neurochem Int 24:485-493 (Pubitemid 24169907)
12. Gandhi S, Wood NW (2005) Molecular pathogenesis of Parkinson's disease. Hum Mol Genet 14:2749-2755 (Pubitemid 41300647)
13. Hanrott K, Gudmunsen L, O'Neill MJ, Wonnacott S (2006) 6-Hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase-3-dependent activation of protein kinase c-delta. J Biol Chem 281(9):5373-5385 (Pubitemid 43847631)
14. Hirsch T, Susin SA, Marzo I, Marchetti P, Zamzami N, Kroemer G (1998) Mitochondrial permeability transition in apoptosis and necrosis. Cell Biol Toxicol 14:141-145 (Pubitemid 28123604)
15. Honda K, Shimohama S, Sawada H, Kihara T, Nakamizo T, Shibasaki H, Akaike A (2001) Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J Neurosci Res 64:466-475 (Pubitemid 32521766)
16. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53:26-36 (Pubitemid 36368560)
17. Junghans U, Kappler J (1999) Rat neocortex. In: Haynes LW (ed) The neuron in tissue culture, IBRO Handbook series: methods in the neurosciences, vol 18. John Wiley and Sons, Chichester, p 545-553
18. Kajta M, Lasoń W, Kupiec T (2004) Effects of estrone on NMDA- and staurosporine-induced changes in caspase-3-like protease activity and LDH-release: time- and tissue-dependent effects in neuronal primary cultures. Neuroscience 123:515-526 (Pubitemid 38032927)
19. Kajta M, Domin H, Grynkiewicz G, Lasoń W (2007) Genistein inhibits gluta mate-induced apoptotic processes in primary neuron al cell cultures: an involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase kinase-3beta intracellular signaling pathway. Neuroscience 145:592-604 (Pubitemid 46341646)
20. Kajta M, Wójtowicz A, Maćkowiak M, Lasoń W (2009) Aryl hydrocarbon receptor-mediated apoptosis of neural cells: a possible interaction with estrogen receptor signaling. Neuroscience 158:811-822
21. Kajta M, Rzemieniec J, Litwa E, Lasoń W, Lenartowicz M, Krzeptowski W, Wojtowicz AK (2013) The key involvement of estrogen receptor β and G-protein-coupled receptor 30 in the neuroprotective action of daidzein. Neuroscience 238:345-360. doi: 10.1016/j.neuroscience.2013.02.005
22. Kotake Y, Tasaki Y, Makino Y, Otha S, Hirobe M (1995) 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem 65(6):2633-2638
23. Kotake Y, Yoshida M, Ogawa M, Tasaki Y, Hirobe M, Ohta S (1996) Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in mouse brain and parkinsonian CSF. J Neurochem 65:2633-2638
24. KotakeY Y, Ohta S, Kanazawa M, Sakurai (2003) Neurotoxicity of an endogenous brain amine, 1-benzyl-1,2,3,4-tetrahydroisoquinoline, in organotypic slice co-culture of mesencephalon and striatum. Neuroscience 117:63-70 (Pubitemid 36246504)
25. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuama H, Rakic P, Flavell RA (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-372 (Pubitemid 26408520)
26. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
27. Lorenc-Koci E, Antkiewicz-Michaluk L, Wardas J, Zapała M, Wierońska J (2004) Effect of 1,2,3,4-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal dopaminergic system. Brain Res 1009:67-81 (Pubitemid 38553849)
28. Mattson MP (2003) Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 3:65-94 (Pubitemid 37012494)
29. McLaughlin BA, Nelson D, Erecinska M, Chesselet MF (1998) Toxicity of dopamine to striatal neurons in vitro and potential of cell death by a mitochondrial inhibitor. J Neurochem 70:2406-2415 (Pubitemid 28252366)
30. Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28:57-87 (Pubitemid 41098899)
31. Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davies RJ et al (2001) Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 21:7551-7560 (Pubitemid 32904954)
32. Mytilineou C, Kototos Leonardi E, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen G, Warren C, Olanow (1998) Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutation depletion. J Pharmacol Exp Ther 284:700-706 (Pubitemid 28086661)
33. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Galland M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43
34. Nicotera P, Brune B, Bagetta G (1997) Nitric oxide: inducer or suppressor of apoptosis? Trends Pharmacol 18(6):189-190 (Pubitemid 27283646)
35. Okada T, Shimada S, Sato K, Kotake Y, Kawai H, Ohta S, Tohyama M, Nishimura T (1998) Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine transporter expressed in HEK293 cells. Neurosci Res 30:87-90 (Pubitemid 28119152)
36. Pompeiano M, Blaschke AJ, Flavell RA, Srinivasan A, Chun J (2000) Decreased apoptosis in proliferative and postmitotic regions of the caspase-3-deficient embryonic central nervous system. J Comp Neurol 423:1-12 (Pubitemid 30407785)
37. Sas K, Robotka H, Toldi J, Vecsei L (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynureine system, with focus on neurodegenerative disorders. J Neurol Sci 257:221-239 (Pubitemid 46856508)
38. Shavali S, Ebadi M (2003) 1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis. Neurotoxicology 24:417-424 (Pubitemid 36705891)
39. Shavali S, Carlson EC, Swinscoe JC, Ebadi M (2004) 1-Benzyl-1,2,3,4- tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases α-synuclein expression and causes nuclear damage in human dopaminergic cells. J Neurosci Res 76:563-572 (Pubitemid 38580471)
40. Wa̧sik A, Romańska I, Antkiewicz-Michaluk L (2009) 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies. Neurotox Res 15:23-31
41. Zhang YM, Bhavnani BR (2005) Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. BMC Neurosci 6:13 (Pubitemid 41418261)